Loading: 15 ?g of lysates per lane. Antibodies: RIP3 (MBS150424), (0.5 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution
Loading: 15 ug of lysates per lane. Antibodies: RIP3 MBS150424, 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Lane 1: MBS150424, 0.1 ug/mL in the presence of peptide blocking Lane 2: MBS150424, 0.1 ug/mL Lane 3: MBS150424, 0.2 ug/mL Lane 4: MBS150424,0.5 ug/mL
Loading: 15 ug of lysates per lane. Antibodies: RIP3 MBS150424,(0.5 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Immunohistochemical analysis of paraffin-embedded rat kidney tissue using anti-RIP3 antibody (MBS150424) at 5 ug/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 uC. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary.Counter stained with Hematoxylin.
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue using anti-RIP3 antibody (MBS150424) at 2.5ug/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 uC. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary.Counter stained with Hematoxylin.
Immunofluorescent analysis of 4% paraformaldehyde-fixed Rat Kidney tissue labeling RIP3 with MBS150424 at 20ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).
Western blot analysis of RIP3 with anti-RIP3 antibodies shows disrupted RIP3 expression in pancreas, liver spleen thymus and lung of RIP3 KO mice. Cerulein treatment upregulated RIP3 expression in the pancreas of WT mice.
RIP3 expression detected by anti-RIP3 antibodies (MBS150424) was decreased in Fadd KO mice as compared to WT mice.
Western blot analysis of RIP3 with anti-RIP3 antibodies shows disrupted RIP3 expression in RIP3 KO MEFs, but not in WT MEF cells.
Immunoblot analysis of RIP3 with anti-RIP3 antibodies (MBS150424) shows RIP3 expression was disrupted in RIP3 knockdown L929 cells.
Confocal microscopy shows colocalization of RIPK1 (green) and RIPK3 (red) in PM and RIPK3 was detected by anti-RIPK3 antibodies (MBS150424). PF or BCM suppressed LPS-induced upregulation of RIP3.
The cancer cell lines were stably expressing DYKDDDDK-tagged RIP3 and RIP expression was detected by anti-RIP3 antibodies (MBS150424) in RIP3-overexpressed cells.